From: Risk factors of postoperative recurrences in patients with clinical stage I NSCLC
Factor | Locoregional recurrence | Distant metastasis | ||
---|---|---|---|---|
OR (95% CI) | p-value | OR (95% CI) | p-value | |
SUVmax 3 3.3 | 1.193 (0.373–3.818) | 0.766 | 1.430 (0.470–4.735) | 0.608 |
CEA 3 3.5 ng/mL | 2.545 (0.810–8.001) | 0.110 | 3.505 (1.138–10.795) | 0.029 |
Tumor size > 2 cm | 1.243 (0.377–4.098) | 0.721 | 3.349 (0.668–16.782) | 0.142 |
Differentiation | 4.902 (1.541–15.625) | 0.007 | 1.615 (0.186–2.062) | 0.434 |
LVSI | 2.103 (0.462–9.573) | 0.336 | 1.430 (0.365–5.601) | 0.608 |